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ABSTRACT 
Objective: The decline in the use of herbal medicine especially in the Western world may be due to lack of readily available market brand 
formulations and the fact that most herbal remedies are taken as tea, decoctions and infusions. The taste of some of these herbal drugs is not 
palatable, and some have unpleasant odour and colour hence, the need to formulate these drugs in form of encapsulated dosage forms. The 
objective of the work was to formulate solid lipid microparticles (SLMs) loaded with the methanolic extract of Garcinia kola seed.  
Methods: The SLMs containing 1 and 3 % of Garcinia kola seed extract were formulated using fat from Capra hircus and Phospholipon® 90H (3:1). 
The particle morphology and size, encapsulation efficiency (EE%), pH, in vitro release and the inhibition zone diameter (IZD) of the SLMs were 
determined.  
Results: The results showed that the extract was very bitter while, the encapsulated G. kola had slight bitter taste. The pH remained in the acidic 
region from 1 to 30 days. Particle size of 28.65 ± 1.13 and 29.49 ± 1.24 µm were obtained for SLMs loaded with 1 and 3 % of the extract respectively. 
SLMs had high EE% of 94 % and also exhibited good release of the extract in simulated intestinal fluid (SIF, pH 7.2). Garcinia kola-loaded SLMs had 
good activity against Staphylococcus aureus and no action against Escherichia coli.  
Conclusion: Therefore, Garcinia kola seed extract could be formulated as SLMs in order to mask its bitter taste and improve compliance. 
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INTRODUCTION 
Herbal medicine is the oldest form of healthcare known to mankind 
[1]. Herbs have been used by all cultures throughout history. It was 
an integral part of the development of modern civilization. Primitive 
man observed and appreciated the great diversity of plants available 
to him. The plants provided food, clothing, shelter and medicine. 
Many drugs commonly used today are of herbal origin. Some are 
made from plant extracts; others are synthesized to mimic a natural 
plant compound [1].   
A lot of studies are being carried out on medicinal plant, and the 
potency of most of these medicinal plants has been established. 
Therefore, there is need to formulate and standardize these herbal 
drugs in order to encourage its use in the treatment of various 
ailments. Formulation, standardization and quality control is needed 
in order to improve patient acceptability and compliance and to 
ensure the purity, potency and efficacy of these herbal drugs. Efforts 
have recently been made in order to formulate herbal drugs into 
various dosage forms [2,3,4]. The advantages of herbal drugs include 
low toxicity, easy availability, low cost, highly efficacious, and form 
the basis for the development of synthetic medicine among others. 
The decline in the use of herbal medicine especially in the western 
world may be due to lack of readily available market brand 
formulations of these products, the fact that most herbal remedies 
are taken as tea, decoctions and infusions. The taste of some of these 
herbal drugs is not palatable, and some have unpleasant odour and 
colour hence, the need to formulate these drugs in form of 
encapsulated dosage forms. 
Solid lipid microparticles (SLMs) attract increasing attention as 
alternative delivery systems and combine the advantages of 
different traditional carriers [5]; the solid matrix protects loaded 
labile substance against degradation and they offer the possibility of 
controlled drug release and drug targeting [6], and has been 
investigated as a taste – masking delivery system of some drugs [7].  
Lipid based formulations have been shown to enhance the 
bioavailability of drugs administered orally [8,9,10,11]. The proven 
safety (biocompatibility) of lipid based carriers makes them 
attractive candidates for the formulation of pharmaceuticals. Lipid 
based formulations promotes wetting or solubilization of drugs and 
enhances permeability or further undergoes intraluminal processing 
to solubilize the drug [8].  
Garcinia kola Heckel (Guttiferae) is a tropical plant whose seed is 
generally known as bitter kola [10]. G. kola is used in folklore 
remedies for the treatment of ailments such as liver disorders, 
hepatitis, diarrhea, laryngitis, bronchitis and gonorrhea [11,12]. The 
seed is masticatory and also used to prevent and relieve colic, chest 
colds, cough and can as well be used to treat headache [13, 14].  Iwu 
[11] reported the use of this plant for the treatment of jaundice, high 
fever and as purgative. The plant also found usefulness in the 
treatment of stomach ache and gastritis [13, 15].  The anti-ovulation 
properties of the seed extract have been reported [16,17]. 
Phytochemical analysis of extracts from both root, stem and seed of 
Garcinia kola show that they contain reasonable amounts of phenolic 
compounds including biflavonoids (GB-1,GB-2), xanthones and 
benzophenones [18,19,20]. Their antibacterial activities are due to 
flavonoids especially biflavonoid type GB1 [13], and this has been 
demonstrated using methicillin-resistant Staphylococcus aureus 
(MRSA), vancomycin- resistant enterococci (VRE) [21], Lactobacillus 
spp. [22] and Streptococcus pyogenese [23].  
Garcinia kola seeds possess properties that is of immense 
ethnomedicinal use to mankind and because of the popular and 
widespread use of this herbal drug, important technical aspects such 
as standardization and formulation of a highly efficacious 
formulation will be of immense benefit in order to enhance their 
efficacy and improve patient’s compliance. Therefore, the aims of the 
present study were to formulate the methanolic extract of Garcinia 
kola seed into solid lipid microparticle, to study the antimicrobial 
properties of the formulations and also determine the organoleptic 
properties of the SLMs. 
MATERIALS AND METHODS 
Materials 
Phospholipon® 90H (Phospholipid GmbH, köln, Germany), Soluplus® 
(BASF, Germany), activated charcoal (Bio-Lab (UK) limited, London), 
distilled water (STC UNN, Nigeria), methanol, sorbic acid, sorbitol 
(Merck, Darmstadt, Germany). Garcinia kola seeds were purchased 
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from a local market in Orba Nsukka, Enugu state, Nigeria in the 
month of June, 2012 and were authenticated by Mr. A.O. Ozioko, a 
consultant taxonomist with the International Center for Ethno 
medicine and Drug Development (InterCEDD) Nsukka and the 
voucher specimen (no. PC98032) is preserved in the Pharmacognosy 
Herbarium, University of Nigeria, Nsukka. Goat fat was extracted 
from Capra hircus.  
Extraction of goat fat  
The goat fat was extracted from Capra hircus by grating the adipose 
tissue prior to boiling with half its weight of water on a water bath 
for 45 min. The molten fat was separated from the aqueous phase 
using a muslin cloth. Further purification was carried out by heating 
a 2% w/w suspension of a 1:9 ratio blend of activated charcoal and 
bentonite in the lipid at 80 to 90°C for 1 h. Thereafter, the 
suspension was vacuum-filtered using Buchner funnel [9].  
Extraction of Garcinia kola 
About 5 kg of Garcinia kola (Heckel) seed were cut into pieces, sun 
dried for 3 days and then pulverized using an end runner mill 
(Pascal Engineering Co Ltd, England). The fine powder (310 g) was 
extracted with methanol by cold maceration method for 24 hours. 
The methanol was allowed to evaporate and a yield of 20.3 g (5.63 
%) was obtained. 
Preparation of lipid matrix 
The lipid matrix consisted of Phospholipon® 90H and purified goat 
fat at a ratio of 1:3. The lipids were weighed and melted together in a 
crucible using a magnetic stirrer hot plate (SR1 UM 52188, Remi 
Equip., India) at 70 oC and stirred with a glass stirrer until a 
transparent homogenous white melt was obtained. The lipid matrix 
was stirred continuously until it solidified at room temperature [5]. 
Preparation of Garcinia kola seed extract-loaded SLMs 
The SLMs were formulated by melt homogenization; the details of its 
composition are shown in Table 1. About 5 g of the lipid matrix was 
weighed using analytical balance (Adventurer, Ohaus, China), melted 
in a beaker at a temperature of 70 oC using a magnetic stirrer hot 
plate (SR1 UM 52188, Remi Equip., India) and the appropriate 
amount of Garcinia kola seed extract was dispersed homogenously 
in the molten lipid. Sorbitol was dissolved in hot distilled water at 
the same temperature with the lipidic melt together with Soluplus® 
(surfactant) and sorbic acid (preservative). The hot aqueous phase 
was transferred into the molten lipid dispersion and immediately 
subjected to high shear homogenization with Ultra-Turrax 
homogenizer (T25 Basic, Digital, Ika Staufen, Germany) at 5000 rpm 
for 10 min. SLMs containing extract (bland SLMs) was also 
formulated [9]. 
 
Table 1: Contents of SLMs loaded with the methanolic extract of Garcinia kola seed 
 


















P1 1 5 4 0.75 0.05 100 
P2 3 5 4 0.75 0.05 100 
P3 0 5 4 0.75 0.05 100 
P1 and P2 contain 1 and 3 % of Garcinia Kola extract, batch P3 is the bland SLMs 
Determination of organoleptic properties  
The odour, taste and colour of the Garcinia kola seed extract-loaded 
SLMs were determined.  
Analysis of particle size and morphology 
The particle size of the microparticles was determined by 
computerized image analysis of at least one hundred microparticles. 
Each of the batches was placed on a microscope slide, covered with a 
cover slip and imaged under a binocular microscope (Lieca, 
Germany) attached with a Motic image analyser (Moticam, China), at 
a magnification of x 100. The particle morphologies were also 
observed and photomicrographs taken.  
The pH studies 
The pH of the SLMs was determined in time dependent manner (24 
hours, 1week, and 1month) using pH meter (Suntex TS-2, Taiwan). 
Encapsulation efficiency and loading capacity  
Beer’s calibration curve was obtained for Garcinia kola extract in 
simulated intestinal fluid (SIF, pH 7.2) at a concentration range of 
0.1 – 1.0 mg/ml at a predetermined wavelength of 285 nm. 
Approximately 10 ml of the Garcinia kola extract-loaded SLMs was 
added into a centrifuge and separated (Chem. Lab. Instrument, UK) 
at 1,252 × g for 30 min. About 0.5 g of the sediment was adequately 
analyzed for drug content using a spectrophotometer (UNICO 2102 
PC UV/Vis Spectrophotometer, USA). The drug content was 
calculated with reference to Beer’s calibration curve. The 
encapsulation efficiency (EE %) of the Garcinia kola in the SLMs was 
calculated from the equation below: 
Encapsulation Efficiency (EE %) = 100x
TDC
ADC
                  (1)  
where ADC is the actual drug content and TDC is the theoretical drug 
content [24].  
 
The LC was determined using the relationship 
 
                                                      (2)                                                             
Where Wl is the weight of lipid in the formulation, Wa is the weight 
of Garcinia kola extract added to the formulation and Ws is the 
actual amount of Garcinia kola extract encapsulated in the 
lipospheres [25]. 
Inhibition zone diameter (IZD) test 
The plate agar diffusion method was used for this study conducted 2 
weeks after the preparation. This method depends on the diffusion 
of antibiotics from holes on the surface of the microbial seeded agar. 
Molten nutrient agar (20 ml) was inoculated with 0.1ml of 
Staphylococcus aureus broth culture. It was mixed thoroughly, 
poured into sterile Petri dishes and rotated for even distribution of 
the organism. The agar plates were allowed to set and a sterile cork 
borer (8 mm diameter) was used to bore three cups in the seeded 
agar medium. The process was first validated using the crude drug 
extract in order to confirm the sensitivity of the microbial culture to 
the inhibitory action of Garcinia kola extract then, different 
concentrations (500, 250 and 125 mg/ml) of the Garcinia kola 
extract, the SLMs and the reference sample (tetracycline), 
respectively, were prepared. A 0.01-ml volume of each of the 
samples was added, respectively, into the different cups in each of 
the plates using Pasteur pipettes. The plates were allowed to stand 
at room temperature for 15 min to enable the samples to diffuse into 
the medium before incubating at 37 oC for 24 h. The diameter of each 
inhibition zone was measured and the average determined 
[26,27,28]. The procedure above was repeated for Escherichia coli. 
In vitro release of Garcinia kola extract from the SLMs 
The USP XXII rotating paddle apparatus (Erweka, Germany) was 
employed for this release study. The dissolution medium consisted 
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of 500 ml of freshly prepared simulated intestinal fluid (SIF pH 7.2) 
maintained at 37 ± 1 oC. The polycarbonate dialysis membrane 
selected as release barrier was pretreated by soaking in the 
dissolution medium for 24 h prior to use (MWCO 6000-8000, 
Spectrum Labs, Brenda, The Netherlands). A 10 ml quantity of the 
SLMs was placed in the polycarbonate dialysis membrane containing 
2 ml of the dissolution medium, securely tied with a thermo–
resistant thread and placed in the chamber of the release apparatus. 
The paddle was rotated at 100 rpm, and at predetermined timed 
intervals, 5 ml-portion of the dissolution medium was withdrawn, 
appropriately diluted, and analysed for the content of the extract in a 
spectrophotometer (UNICO 2102 PC UV/Vis Spectrophotometer, 
USA) at a predetermined wavelength of 285 nm. Sink condition was 
maintained by replacing with an equal volume of the withdrawn 
medium. The amount of extract released at each time interval was 
determined with reference to Beer’s Plot. 
Statistical analysis 
Statistical analysis was performed using SPSS version 16.0 (SPSS Inc. 
Chicago, IL.USA). Data were analyzed by one-way ANOVA. 
Differences between means were assessed using student’s t-test.  
RESULTS AND DISCUSSION 
Organoleptic properties  
The results of the organoleptic properties of Garcinia kola seed 
extract-loaded SLMs are shown in Table 2 and show that the extract 
was brown in colour, the bland SLMs had light yellow colour while, 
the Garcinia kola-loaded SLMs were light brown. The extract was 
very bitter but, the encapsulated G. kola had slightly bitter taste. 
Therefore, the SLMs had taste masking effect and could be a better 
delivery system for this herbal drug in order to adequately present a 
suitable dosage form that will be acceptable to patients so as to 
improve compliance.  
Table 2: The organoleptic properties of Garcinia kola-loaded 
SLMs 
Batches Colour Odour Taste 
P1 Light brown Sweet smell Slightly bitter 
P2 Light brown Sweet smell Slightly bitter 
P3 Yellow Pleasant Salty 
P4 (extract) Brown Pleasant Very bitter 
P1, P2 and P3 SLMs contain 1 and 3 % of Garcinia Kola extract, 
batch P3 is the bland SLMs and P4 is the Garcinia Kola extract. 
The pH of SLMs 
The results of the pH of the G. kola-loaded and the bland SLMs are 
shown in  Fig. 1 and show that the unloaded SLMs had pH of 6.4, 5.5 
and 4.7 at 1, 7 and 30 days respectively. When Garcinia kola was 
incorporated into the SLMs, the pH remained in the acidic region 
throughout the study period. The results showed that the pH of the 
formulations were stable. However, the slight pH decline seen in the 
SLMs may be due to the degradation of the fatty acid components of 
the individual lipids that made up the lipid matrix, since there was 
also a decline in the pH of the bland SLMs [25,26]. 
 
 
Fig. 1: Time dependent pH stability of Garcinia kola-loaded 
SLMs; P1, P2 and P3 SLMs contain 1 and 3 % of Garcinia Kola 
extract, batch P3 is the bland SLMs and P4 is the Garcinia Kola 
extract. 
Particle size and morphology 
The results of the part size of the SLMs are shown in Table 3, and 
show that Garcinia kola-loaded SLMs had particle size of 28.65 ± 
1.13 and 29.49 ± 1.24 µm for P1 and P2 loaded with 1 and 3 % of the 
extract respectively, while the bland SLMs had particle size of 21.06 
± 1.17 µm. The results therefore, showed that particle size increased 
with increase in drug loading in agreement with previous works 
[5,24,29]. However, particle size of SLMs is important because they 
have direct bearing on the bioavailability of the encapsulated active 
pharmaceutical ingredient and the site of administration. The results 
show that the particles were within the acceptable range for 
microparticles. The results of the particle morphology shown in Fig. 
2 showed that the particles were spherical as expected for SLMs. 
















P1    1 0.92 ± 
0.32 
  92.3        1.57 28.65 ±  
1.13  
P2    3 2.81 ± 
0.15 
  93.5       3.66 29.49 ± 
1.24 
P3    -       -    -     - 21.06 ± 
1.17 
 
*Mean ± standard deviation, †n = 100; ††n = 3, P1, P2 and P3 
SLMs contain 1 and 3 % of Garcinia Kola extract, batch P3 is the 
bland SLMs; TDC: Theoretical drug content, ADC: Actual drug 
content; EE: Encapsulation efficiency; LC: Loading capacity. 
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Fig. 2: Photomicrographs of SLMs, P1, P2 and P3 SLMs contain 1 
and 3 % of methanolic extract of Garcinia Kola seed, batch P3 is 
the bland SLMs. 
Encapsulation efficiency and loading capacity 
The encapsulation efficiency was calculated using the ADC and the 
TDC with reference to Beer-Lamberts calibration curve obtained for 
Garcinia kola extract in simulated intestinal fluid without enzyme 
shown in Fig. 3. The results of the encapsulation efficiency shown in 
Table 3 revealed that the SLMs exhibited high encapsulation of the 
extract. This formulation technique is good for encapsulating herbal 
extract in order to mask the taste and odour of these formulations. 
The lipid matrix had a loading capacity of up to 3. 7 g API/100 g lipid 
and increased with increase in the amount of extract incorporated as 
shown in Table 3.  
The ability of the SLM to accommodate active molecules is an 
important property and this can be expressed by the encapsulation 
efficiency (EE %) and loading capacity. EE% defines the ratio 
between the weight of entrapped drug and the total weight of drug 
added to the dispersion, while LC expresses the ratio between the 
entrapped drug and the total weight of the lipids [5]. 
 
 
Fig. 3: Standard Beer-Lamberts plot for the extract of Garcinia 
kola seed in SIF, pH 7.2 
 In vitro release  
The results of the in vitro release of the extract from the SLMs are 
shown in Fig. 4 and the results show that batch P1 containing 1 % of 
Garcinia kola extract had 19.5, 42.4 and 59.1 % release while, batch 
P2 containing 3 % of the extract had 34.4, 37.8, 64.2 % release at 5, 
30 and 100 min respectively. The results showed an initial high 
release at 5 min in both formulations which may be due to the 
presence of loosely bound extract in the periphery of the SLMs 
giving rise to an effect like an initial burst. The results showed that 
the SLMs had good release of the extract in SIF and could be a better 
delivery system for this herbal extract in order to improve patient 
acceptability and compliance of this herbal drug. 
 
 
Fig. 4: In vitro release of Garcinia kola seed extract from SLMs in 
SIF, pH 7.2 
Antimicrobial properties 
The results of the inhibition zone diameter of the methanolic seed 
extract of Garcinia kola-loaded SLMs are shown in Table 4 and 
results show that the SLMs formulations (P1 and P2) had IZDs of 
about 15 to 15.6 mm. However, the reference sample (tetracycline) 
had significantly higher IZD than the test SLMs (p< 0.05). The results 
also showed that Garcinia kola-loaded SLMs had good activity 
against Staphylococcus aureus and no action against E. coli. The 
results show that the properties of the extract were not destroyed by 
the production process adopted in the study. 
Table 4: Antimicrobial properties of Garcinia kola extract- 
loaded lipospheres 
        Batches     Staphylococcus aureus Escherichia coli 
                    IZD (mm)*†  
           P1                  15.0 ± 0.17             - 
           P2                  15.6 ± 0.72**             - 
Tetracycline                   25.0 ± 0.53            35 ± 0.83 
Extract                  16.0 ± 0.23             - 
 
Notes: IZD: Inhibition zone diameter; *mean ± SD, †n= 3; ** p < 
0.05 was considered to be significantly different from the 
reference, P1 and P2 SLMs contain 1 and 3 % of Garcinia Kola 
extract. 
CONCLUSION 
SLMs loaded with methanolic seed extract of Garcinia kola had good 
properties against S. aureus and no activity against E. coli. The 
particle size revealed spherical particles within the micrometer 
range for microparticles. High encapsulation efficiency of up to 94 % 
was obtained for the extract and had good taste masking properties. 
This delivery system could be employed in the delivery of herbal 
drugs in other to enhance oral bioavailability, enhance patient 
compliance and acceptability of the formulation. 
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